SMS Pharmaceuticals Ltd — Major Shareholding Notification 2020

Dec 21, 2020

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel : +91-40-25259999, Fax: +91-40-25259889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

21't December, 2020

To BSE Limited, Listing Depart ment, P J Towers, Da lal Street, Mumbai - 400 OOL Scrip code: 532815

National Stock Exchange of India Limited, Listi ng Depa rtme nt, "Exchange Plaza", Ba ndra-Kurla Complex, Bandra (E), Mum ba i - 400 051. Trading Symbol: SMSPHARMA

Dear Sir / M adam,

SUB: INTIMATION REGARDING INTERS-SE TRANSFER BETWEEN PROM OTERS/PROM OTER GROUP Ref: Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 read with Regu lation 3 of SEBI (prohibition of Insider Trading) Regulation 2015.

We would like t o inform your office that the Company has received int imation from M/s Pot luri Infra Projects LLP - Promoter Group, t hat intended to acquire 6,61,180 (six lakhs sixty one thousa nd one hundred eighty) Equity Shares of the Company by way of inter-se transfer on or after December 29, 2020, in terms of Regulation 10(1)(a)(ii) of SE BI (SAST), Regulations2011

The details of t he sam e are ment ioned below:

Name of Person (Acquirer)	Name of the (Seller)		of No.		shares	%	of
			proposed	to	be	share holding
			transferred
M/s Potluri Infra Projects LLP	- Mr. Murthy TVVSN		6,61,180			0.78
- Promoter Group	Promoter
Total			6,61,180			0.78

The above proposed acquisitions shall qualify as "inter-se transfer" under reg. 10(1)(a)(ii) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and there will be no change in the aggregate shareholding of the Promoter Group

Kindly take the same on record and suitably disseminate to all concerned.

Thanking you,

YO~

V S Venkatish Company secretary

Encl: a/a

~? Potluri Infra Projects LLP

Door No.7-1-618/NG/416, Nilgiri, Aditya Enclave,Ameerpet, Hyderabad-500038.Telangana Tel NO.9348477899 Email.potluriinfra@gmail.com LLP Identification No.AAG-0853

Date: 21st December, 2020

From

rNs Potluri Infra Projects LLP (Promoters & Promoter group of SMS Pharmaceuticals Limited) Plot. No. 265 Q Road No. 10, Jubilee Hills, Hyderabad - 500033 T5

To

CSE Limited, Listing Department, P J Towers, Dalal Street, Mumbai - 400 001. Scrip code: 532815

National5tock Exchange of India Limited, Listing Department, "Exchange Plaza", Bandra-Kurla Complex, Sandra (E), Mumbai - 400 05lo Tr,ading Symbol: SMSPHARMA

::. :PI-P

Email:corp.relations@bseindia.com corp.comm@bseindia.com

Email: takeover@nseindia.com

To,

Company Secretary & Compliance :officer SMS Pharmaceuticals Limited Plot.no. 72, H.No. 8-2-334/3&4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills Hyderabad 500034.

Dear Sir,

.sUB::DISCLOSURE{Sj UNDER REGULATION 10(5) OFTHE:SE.BI (SAST) 'REGULATJON, .20ll Ref: Name .of the Target Company: 'SMS Pharmaceuticals Umited -ISIN:INE812GOI025.

We hereby 2iubmitdisc!oSl,lres as required under Regulation 10(5) of SASTRegulations,2011 'for acquisition of 6,'61,180 Equity shares of SMS 'Pharmaceuticals Umited.

Kindly take the same on records and acknowledge the receipt of the same.

Yours truly,

czou, ~

Vamsi Krishna Potluri On behalf of Potluri Infra Projects lLP Designated Partner

Encl as above

Format for Disclosures under Regulation 1O(5) -lntimation to Stock Exchanges in respect of acquisition under Regulation 1 O( 1 )(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations. 20 11

l.	Name of the Target Company (TC)		\$MS Pharmaceuticals Limited
2.	Name of the acquirer(s)	MIs Potluri Infra Projects LLP
3.	Whether the acquirer(s) isl are promoters of the Promoter and Promoter Group
	TC prior to the transaction. If not. nature of
	relationship or association with the TC or its
	promoters
4.	Details of the proposed acquisition
	a. Name of the person(s) from whom shares are to be acquired		Mr. TVVSN Murthy
	b. Proposed date of acquisition	On or after December 29. 2020
	c. Number of shares to be acquired from each	Sl no.	Name of seller	No of shares
	person mentioned in 4(a) above	1)	Mr. TVVSN Murthy	6.61.1 80 (0.78%)
	d. Total shares to be acquired as % of capitalofTC	0.78%
	e. Price at which shares are proposed to be		Price not exceeding the limits provided in proviso (i) to
	acquired		Regulation 1 O( 1 )(a) of the SEBI SAST Regulations.
	Rationale. if any. for the proposed transfer f.		nter-se transfer of equity shares of SMS Pharmaceuticals
			Limited between members of Promoter and Promoter Group
			Persons acting in concert.
5.	Relevant sub-clause of regulation 1O( 1 )(a) under		Regulation 1 O( 1 )(a)(ii) of the SEBI SAST Regulations.
	which the acquirer is exempted.from making
6.	open offer
	If. frequently traded. volume weighted average The Shares of the TC are frequently traded in terms of market price for a period of 60 trading days Regulation 2(i)U) of the SEBI SAST Regulations. the Volume
	preceding the date of issuance of this notice as Weighted Average Market Price for a period of 60 trading
	traded stock exchange where on the		the days preceding the date of issuance of this notice as traded
	maximum volume of trading in the shares of the on the Stock Exchange where the maximum value of
	TC are recorded during such period.		rading in the share of the TC are recorded during such
			period is Rs. 94.37 per shares.
7.	If in-frequently traded. the price as determined in Not Applicable
	terms of clause (e) of sub-regulation (2) of
	regulation 8.
8.	Declaration by the acquirer. that the acquisition The acquisition price would not be higher more than 25% of
	price would not be higher by more than 25% of he price computed in point no. 6 herein above.
	the price computed in point 6 or point 7 as applicable.
9.	Declaration by the acquirer. that the transferor The transferors and transferees have complied (during 3
	and transferee have complied I will comply with years prior to the date of the proposed acquisition) I will
	applicable disclosure requirements in Chapter V comply with applicable disclosure required under Chapter
	of Regulations. the Takeover		2011 V of the SEBI SAST Regulations.
	(corresponding provisions of the repealed
	Takeover Regulations 1997)		/l	~ ~(~ ,!!: ~ ()
			- ~ ,	~ 0 " r- * <>'

10.		Declaration acquirer that the by the all	[we hereby declare that all the conditions specified under
		conditions specified under regulation 10(1 )(a)	egulation lO(l )(a) of the SEBI SAST Regulations with
	with	respect to exemptions has been duly	espect to exemptions has been duly complied with.
		complied with.
I I.	Shareholding details		Before the		After the
			proposed		proposed
			transaction		transaction
			No. of shares voting rights	%w.r.t total share	No. of shares	% w.r.t total share
				capital of	Ivoting	capital of
				TC	rights	TC
	a	Acquirer(s) and PACs (other than sellersW)
		Mis PotIuri Infra Projects LLP i.	66.85.240	7.90%	73.46.420	8.68%
	b	Seller (s)
/-"		Mr. 1VVSN Murthy i.	6.61.180	0.78%	0	0

Vamsi li~ ~ Krishna Potluri On behalf of Potluri Infra Projects LLP Designated Partner

~B.A p~

Place, Hyderabad Date, December 21. 2020